Clinical interpretation of antineutrophil cytoplasmic antibodies: Parvovirus B19 infection as a pitfall

Annals of the Rheumatic Diseases

Volumn 64, Issue 4, 2005, Pages 641-643

  Hermann, Josef ^a   Demel, U ^a   Stunzner D ^a   Daghofer, E ^a   Tilz, G ^a   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; ERYTHEMA INFECTIOSUM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MONARTHRITIS; PARVOVIRUS; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SYSTEMIC VASCULITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, VIRAL; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN M; MYELOBLASTIN; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PEROXIDASE; SERINE ENDOPEPTIDASES; VASCULITIS;

EID: 16344368294     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.024877     Document Type: Article

References (13)

1. Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, et al. Autoantibody prevalence in chronic hepatitis B virus infection: effect on Interferon alfa. Hepatology 1996;24:520-3.
2. Varani S, Muratori L, De Ruvo N, Vivarelli M, Lazzarotto T, Gabrielli L, et al. Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol 2002;66:56-62.
3. Csernok E, Ahlquist D, Ullrich S, Gross WL. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 2002;41:1313-17.
4. Ohira H, Tojo J, Shinzawa J, Suzuki T, Miyata M, Nishimaki T, et al. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C. Fukushima J Med Sci 1998;44:83-92.
5. Von Landenberg P, Lehmann HW, Knoll A, Dorsch S, Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003;48:1939-47.
6. Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. FASEB J 1992;6:840-4.
7. Gassinotti P, Weitz M, Siegl G. Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J Med Virol 1993;40:228-34.
8. White DG, Mortimer PP, Blake DR, Woolf AD, Cohen BJ, Bacon PA. Human parvovirus arthropathy. Lancet, 1985;i, 419-21.
9. Noritake DT, Weiner SR, Bassett LW, Paulus HE, Weisbart R. Rheumatic manifestations of Wegener's granulomatosis. J Rheumatol 1987;14:949-51.
10. Finkel TH, Torok TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotising vosculitis: opportunistic infection or aetiologicol agent? [see comments]. Lancet 1994;343:1255-8.
11. Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cuton Pathol 2004;31:43-50.
12. Mayet WJ, Schwarting A, Meyer zum Buschenfelde KH. Cytotoxic effects of antibodies to proteinase 3 (c-ANCA) on human endothelial cells. Clin Exp Immunol 1994;97:458-65.
13. Chou TN, Hsu TC, Chen RM, Lin LI, Tsay GJ. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus 2000;9:551-4.